Pharmacological Characterization, Structural Studies, and In Vivo Activities of Anti-Chagas Disease Lead Compounds Derived from Tipifarnib

समान संसाधन

• Second Generation Analogs of the Cancer Drug Clinical Candidate Tipifarnib for Anti-Chagas Disease Drug Discovery
  द्वारा: Kraus, James M., और अन्य
  प्रकाशित: (2010)
• Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agents
  द्वारा: Chennamaneni, Naveen Kumar, और अन्य
  प्रकाशित: (2009)
• The Protein Farnesyltransferase Inhibitor Tipifarnib as a new Lead for the Development of Drugs against Chagas Disease
  द्वारा: Hucke, Oliver, और अन्य
  प्रकाशित: (2005)
• Rational Modification of a Candidate Cancer Drug for Use Against Chagas Disease
  द्वारा: Kraus, James M, और अन्य
  प्रकाशित: (2009)
• Dialkylimidazole inhibitors of Trypanosoma cruzi sterol 14α-demethylase as anti-Chagas disease agents
  द्वारा: Suryadevara, Praveen Kumar, और अन्य
  प्रकाशित: (2013)